CLABSI Prevention: The Complete Evidence-Based Bundle

The complete evidence-based CLABSI prevention guide: CDC/NHSN definitions, insertion bundle, maintenance bundle, CHG bathing, antimicrobial strategies, surveillance, and Zero CLABSI implementation.

6 articles Updated Feb 2026

Needleless Connectors and CLABSI Prevention: Selection, Management, and Evidence

Evidence-based guide to needleless connectors and CLABSI prevention: connector types (split-septum, mechanical valve), scrub-the-hub technique, change intervals, passive disinfection caps, and selecting connectors to minimize CLABSI risk.

CLABSI Maintenance Bundle: Post-Insertion Central Line Infection Prevention

Complete guide to the CLABSI maintenance bundle: scrub-the-hub technique, CHG-impregnated dressings, CHG daily bathing, needleless connector management, administration set change intervals, and daily necessity review per INS 2021 and CDC guidelines.

CLABSI Insertion Bundle: The 5 Elements That Prevent Central Line Infections

Evidence-based guide to the CLABSI insertion bundle: 5 elements (hand hygiene, maximal sterile barrier, CHG antisepsis, optimal site selection, daily necessity review), implementation, and bundle compliance documentation.

CLABSI Definition, Epidemiology, and Surveillance: What Clinicians Need to Know

Complete overview of CLABSI definition (NHSN criteria), epidemiology (incidence, mortality, cost), CLABSI vs CRBSI distinction, NHSN surveillance methodology, SIR benchmarking, and how CLABSI rates are calculated.

Chlorhexidine Gluconate (CHG) in CLABSI Prevention: Evidence and Clinical Application

Evidence-based guide to chlorhexidine gluconate (CHG) in CLABSI prevention: skin antisepsis (2% CHG vs povidone-iodine), CHG-impregnated dressings, daily CHG bathing, application technique, dry time requirements, and CHG safety considerations.

Antimicrobial Catheters and Dressings: Evidence for High-Risk CLABSI Settings

Evidence-based guide to antimicrobial-impregnated catheters (CHG/SS, minocycline-rifampin), antimicrobial dressings, and antimicrobial lock therapy for CLABSI prevention in high-risk settings — indications, evidence, and limitations.